Issued Patents All Time
Showing 1–10 of 10 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10494416 | Methods of modulating immune responses using BCMA polypeptide | Jeffrey Browning, Christine Ambrose, Jurg Tschopp, Pascal Schneider, Jeffrey Thompson | 2019-12-03 |
| 9650430 | Methods of treating autoimmune diseases using a B-cell maturation antigen (BCMA) | Jeffrey Browning, Christine Ambrose, Jurg Tschopp, Pascal Schneider, Jeffrey Thompson | 2017-05-16 |
| 9545086 | BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders | Susan L. Kalled | 2017-01-17 |
| 8828669 | Methods of screening for a compound that inhibits the interaction between BAFF and BCMA | Jeffrey Browning, Christine Ambrose, Jurg Tschopp, Pascal Schneider, Jeffrey Thompson | 2014-09-09 |
| 8287874 | Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases | Jeffrey Browning, Paula S. Hochman, Paul Rennert | 2012-10-16 |
| 7744891 | Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases | Jeffrey Browning, Paula S. Hochman, Paul Rennert | 2010-06-29 |
| 7309492 | Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of systemic lupus erythematosus | Jeffrey Browning, Paula S. Hochman, Paul Rennert | 2007-12-18 |
| 7255854 | Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases | Jeffrey Browning, Paula S. Hochman, Paul Rennert | 2007-08-14 |
| 7083785 | Methods of treatment by administering an anti-BCMA antibody | Jeffrey Browning, Christine Ambrose, Jurg Tschopp, Pascal Schneider, Jeffrey Thompson | 2006-08-01 |
| 6869605 | BAFF, inhibitors thereof and their use in the modulation of B-cell response | Jeffrey Browning, Christine Ambrose, Jurg Tschopp, Pascal Schneider | 2005-03-22 |